Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Oral Hypoglycemic Agents: Sulfonylureas01:17

Oral Hypoglycemic Agents: Sulfonylureas

Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide (Glucotrol),...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of a reverse-phase HPLC method for quantification of gemcitabine in plasma samples of solid tumor patients.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same author

Efficiency and effectiveness of concise evidence-based medicine training program at a tertiary healthcare institute - Exploring the impact on research output of faculty.

Perspectives in clinical research·2026
Same author

Upfront Combined Hydroxyurea and Imatinib versus Imatinib Monotherapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Randomized Controlled Trial.

South Asian journal of cancer·2025
Same author

Outcome of Childhood and Adolescents and Young Adults ALL Treated with ALL IC-BFM 2009 Protocol-A Single-Center Experience in India.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2025
Same author

Multiple myeloma: Insights into underlying mechanisms, advances in diagnostic and therapeutic modalities.

Seminars in oncology·2025
Same author

Antimicrobial prescription patterns in tertiary care centres in India: a multicentric point prevalence survey.

EClinicalMedicine·2025

Related Experiment Video

Updated: May 16, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Metformin: Midlife maturity, maiden charm.

Sanjay Kalra1, Puneet Dhamija, Ashok K Das

  • 1Department of Endocrinology, Bharti Hospital and BRIDE, Karnal, India.

Indian Journal of Endocrinology and Metabolism
|December 11, 2012
PubMed
Summary

Metformin, a common Type 2 diabetes drug, shows promising cardioprotective, hepatoprotective, and nephroprotective effects. Further research may expand its approved uses beyond diabetes management.

Keywords:
Biguanidescancercardioprotectiondiabetesgonadhepatoprotectionoral hypoglycemic drugsrenoprotectionthyroid

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
08:15

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Published on: August 15, 2025

Related Experiment Videos

Last Updated: May 16, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
08:15

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Published on: August 15, 2025

Area of Science:

  • Pharmacology and Therapeutics
  • Endocrinology
  • Oncology
  • Cardiology
  • Hepatology
  • Nephrology

Background:

  • Metformin is a widely prescribed medication for Type 2 diabetes mellitus with a long history of use.
  • Emerging research suggests metformin possesses pharmacological properties applicable to various other medical conditions.
  • The scientific community is increasingly interested in exploring the multifaceted roles of this established drug.

Purpose of the Study:

  • To review the existing evidence on metformin's cardioprotective and hepatoprotective effects.
  • To explore metformin's potential benefits in nephroprotection, weight management, and reproductive health.
  • To summarize metformin's impact on thyroid-stimulating hormone (TSH) levels and its anticancer properties.

Main Methods:

  • Comprehensive literature review of pharmacological studies and clinical evidence.
  • Analysis of research investigating metformin's effects beyond glycemic control.
  • Synthesis of data on metformin's diverse therapeutic actions.

Main Results:

  • Metformin demonstrates significant cardioprotective, hepatoprotective, and nephroprotective potential.
  • Evidence suggests metformin influences body fat regulation and reproductive health.
  • Metformin exhibits TSH-lowering effects and shows activity against various cancer types.

Conclusions:

  • Metformin's established efficacy in diabetes management is complemented by a growing list of potential therapeutic applications.
  • These diverse pharmacological actions, including organ protection and anticancer effects, warrant further investigation.
  • Additional research may lead to expanded clinical indications for metformin in the future.